Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

Publisher Correction: Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria.

Milicic A, Rollier CS, Tang CK, Longley R, Hill AVS, Reyes-Sandoval A.

Sci Rep. 2019 May 3;9(1):7060. doi: 10.1038/s41598-019-43120-x.

2.

Development of an E2 ELISA Methodology to Assess Chikungunya Seroprevalence in Patients from an Endemic Region of Mexico.

Kim YC, López-Camacho C, Garcia-Larragoiti N, Cano-Mendez A, Hernandez-Flores KG, Domínguez-Alemán CA, Mar MA, Vivanco-Cid H, Viveros-Sandoval ME, Reyes-Sandoval A.

Viruses. 2019 May 1;11(5). pii: E407. doi: 10.3390/v11050407.

3.

Assessment of Immunogenicity and Neutralisation Efficacy of Viral-Vectored Vaccines Against Chikungunya Virus.

López-Camacho C, Kim YC, Blight J, Lazaro Moreli M, Montoya-Diaz E, T Huiskonen J, Mareike Kümmerer B, Reyes-Sandoval A.

Viruses. 2019 Apr 3;11(4). pii: E322. doi: 10.3390/v11040322.

4.

51 years in of Chikungunya clinical vaccine development: A historical perspective.

Reyes-Sandoval A.

Hum Vaccin Immunother. 2019 Feb 8:1-8. doi: 10.1080/21645515.2019.1574149. [Epub ahead of print]

PMID:
30735447
5.

A probabilistic model of pre-erythrocytic malaria vaccine combination in mice.

Atcheson E, Bauza K, Reyes-Sandoval A.

PLoS One. 2019 Jan 9;14(1):e0209028. doi: 10.1371/journal.pone.0209028. eCollection 2019.

6.

Optimization of Zika virus envelope protein production for ELISA and correlation of antibody titers with virus neutralization in Mexican patients from an arbovirus endemic region.

Kim YC, Lopez-Camacho C, Nettleship JE, Rahman N, Hill ML, Silva-Reyes L, Ortiz-Martinez G, Figueroa-Aguilar G, Mar MA, Vivanco-Cid H, Rollier CS, Zitzmann N, Viveros-Sandoval ME, Owens RJ, Reyes-Sandoval A.

Virol J. 2018 Dec 27;15(1):193. doi: 10.1186/s12985-018-1104-6.

7.

Rapid travel to a Zika vaccine: are we heading towards success or more questions?

Britto C, Dold C, Reyes-Sandoval A, Rollier CS.

Expert Opin Biol Ther. 2018 Nov;18(11):1171-1179. doi: 10.1080/14712598.2018.1526277. Epub 2018 Oct 4. Review.

PMID:
30235422
8.

Chimeric Plasmodium falciparum parasites expressing Plasmodium vivax circumsporozoite protein fail to produce salivary gland sporozoites.

Marin-Mogollon C, van Pul FJA, Miyazaki S, Imai T, Ramesar J, Salman AM, Winkel BMF, Othman AS, Kroeze H, Chevalley-Maurel S, Reyes-Sandoval A, Roestenberg M, Franke-Fayard B, Janse CJ, Khan SM.

Malar J. 2018 Aug 9;17(1):288. doi: 10.1186/s12936-018-2431-1.

9.

Tailoring a Plasmodium vivax Vaccine To Enhance Efficacy through a Combination of a CSP Virus-Like Particle and TRAP Viral Vectors.

Atcheson E, Bauza K, Salman AM, Alves E, Blight J, Viveros-Sandoval ME, Janse CJ, Khan SM, Hill AVS, Reyes-Sandoval A.

Infect Immun. 2018 Aug 22;86(9). pii: e00114-18. doi: 10.1128/IAI.00114-18. Print 2018 Sep.

10.

Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors.

López-Camacho C, Abbink P, Larocca RA, Dejnirattisai W, Boyd M, Badamchi-Zadeh A, Wallace ZR, Doig J, Velazquez RS, Neto RDL, Coelho DF, Kim YC, Donald CL, Owsianka A, De Lorenzo G, Kohl A, Gilbert SC, Dorrell L, Mongkolsapaya J, Patel AH, Screaton GR, Barouch DH, Hill AVS, Reyes-Sandoval A.

Nat Commun. 2018 Jun 22;9(1):2441. doi: 10.1038/s41467-018-04859-5.

11.

Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge.

de Camargo TM, de Freitas EO, Gimenez AM, Lima LC, de Almeida Caramico K, Françoso KS, Bruna-Romero O, Andolina C, Nosten F, Rénia L, Ertl HCJ, Nussenzweig RS, Nussenzweig V, Rodrigues MM, Reyes-Sandoval A, Soares IS.

Sci Rep. 2018 Jan 18;8(1):1118. doi: 10.1038/s41598-017-19063-6.

12.

Microcrystalline Tyrosine (MCT®): A Depot Adjuvant in Licensed Allergy Immunotherapy Offers New Opportunities in Malaria.

Cabral-Miranda G, Heath MD, Gomes AC, Mohsen MO, Montoya-Diaz E, Salman AM, Atcheson E, Skinner MA, Kramer MF, Reyes-Sandoval A, Bachmann MF.

Vaccines (Basel). 2017 Sep 27;5(4). pii: E32. doi: 10.3390/vaccines5040032.

13.

Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria.

Milicic A, Rollier CS, Tang CK, Longley R, Hill AVS, Reyes-Sandoval A.

Sci Rep. 2017 Aug 4;7(1):7284. doi: 10.1038/s41598-017-07246-0. Erratum in: Sci Rep. 2019 May 3;9(1):7060.

14.

Current trends in Zika vaccine development.

Lagunas-Rangel FA, Viveros-Sandoval ME, Reyes-Sandoval A.

J Virus Erad. 2017 Jul 1;3(3):124-127.

15.

Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax.

Cabral-Miranda G, Heath MD, Mohsen MO, Gomes AC, Engeroff P, Flaxman A, Leoratti FMS, El-Turabi A, Reyes-Sandoval A, Skinner MA, Kramer MF, Bachmann MF.

Vaccines (Basel). 2017 May 2;5(2). pii: E10. doi: 10.3390/vaccines5020010.

16.

Rational development of a protective P. vivax vaccine evaluated with transgenic rodent parasite challenge models.

Salman AM, Montoya-Díaz E, West H, Lall A, Atcheson E, Lopez-Camacho C, Ramesar J, Bauza K, Collins KA, Brod F, Reis F, Pappas L, González-Cerón L, Janse CJ, Hill AVS, Khan SM, Reyes-Sandoval A.

Sci Rep. 2017 Apr 18;7:46482. doi: 10.1038/srep46482.

17.

Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites: Naturally Acquired Humoral Immune Response and B-Cell Epitope Mapping in Brazilian Amazon Inhabitants.

Rodrigues-da-Silva RN, Soares IF, Lopez-Camacho C, Martins da Silva JH, Perce-da-Silva DS, Têva A, Ramos Franco AM, Pinheiro FG, Chaves LB, Pratt-Riccio LR, Reyes-Sandoval A, Banic DM, Lima-Junior JD.

Front Immunol. 2017 Feb 7;8:77. doi: 10.3389/fimmu.2017.00077. eCollection 2017.

18.

Evaluation of Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites as a Preerythrocytic P. vivax Vaccine.

Alves E, Salman AM, Leoratti F, Lopez-Camacho C, Viveros-Sandoval ME, Lall A, El-Turabi A, Bachmann MF, Hill AV, Janse CJ, Khan SM, Reyes-Sandoval A.

Clin Vaccine Immunol. 2017 Apr 5;24(4). pii: e00501-16. doi: 10.1128/CVI.00501-16. Print 2017 Apr.

19.

Detecting circulating antibodies by controlled surface modification with specific target proteins: Application to malaria.

Cardoso AR, Cabral-Miranda G, Reyes-Sandoval A, Bachmann MF, Sales MGF.

Biosens Bioelectron. 2017 May 15;91:833-841. doi: 10.1016/j.bios.2017.01.031. Epub 2017 Jan 15.

PMID:
28157657
20.

Influence of adenovirus and MVA vaccines on the breadth and hierarchy of T cell responses.

Rollier CS, Hill AVS, Reyes-Sandoval A.

Vaccine. 2016 Aug 31;34(38):4470-4474. doi: 10.1016/j.vaccine.2016.07.050. Epub 2016 Jul 30.

Supplemental Content

Loading ...
Support Center